Pilot Study of Genetic Alterations and Clonal Evolution of Relapsed Refractory Adult ALL in Patients Receiving KTE-X19 CAR-T in ZUMA-3 (ZUMA3 Sequencing)

This study is from the ZUMA-3 Phase 1/2 study of adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Patients were treated with KTE-X19, an autologous anti-CD19 CAR T-cell therapy under investigation.

• Type: RNA Sequencing
• Archive: The database of Genotypes and Phenotypes (dbGaP)